Related Experiment Videos
Sleeve segmentectomy for non-small cell lung carcinoma
Morihito Okada1, Wataru Nishio, Toshihiko Sakamoto
1Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan. morihito1217jp@aol.com
The Journal of Thoracic and Cardiovascular Surgery
|September 9, 2004
Summary
Sleeve segmentectomy is a safe and effective lung-sparing surgery for early-stage non-small cell lung cancer. This procedure, a type of bronchoplasty, offers good survival rates for centrally located tumors.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Sleeve segmentectomy was initially for patients intolerant to lobectomy.
- Its application has expanded to patients with adequate pulmonary function.
- This study evaluates the efficacy of sleeve segmentectomy as an atypical bronchoplasty technique.
Purpose of the Study:
- To assess the efficiency and outcomes of sleeve segmentectomy for centrally located non-small cell lung cancer.
- To evaluate the safety and utility of this lung-sparing procedure in a broader patient population.
Main Methods:
- Retrospective analysis of 202 patients undergoing bronchoplasty for primary non-small cell lung cancer.
- Focus on 16 patients who underwent sleeve segmentectomy with various bronchial reconstruction methods.
- Tumor resection and bronchial reconstruction success rates were primary endpoints.
Main Results:
- All 16 patients achieved complete tumor resection with successful bronchial reconstruction.
- No bronchial complications or local recurrences were observed.
- Overall 3-year and 5-year survival rates were 93.3% and 68.1%, respectively, with most patients alive.
Conclusions:
- Sleeve segmentectomy is a technically demanding but safe and useful lung-saving operation.
- It should be considered for centrally located, curable early non-small cell lung cancer.
- Increasing prevalence of small or multiple lung tumors supports the use of this technique.